For the rapid purification of total DNA from bacteriophages.
For research use only and NOT intended for in vitro diagnostics.
Phage DNA Isolation Kit
For the rapid purification of total DNA from bacteriophages.
Register today to receive an exclusive 15% off* on your first order.
Features and Benefits
- Isolate high quality DNA from a broad variety of phage strains
- High yields of total DNA
- Fast and easy processing using a rapid spin-column format
- No phenol or chloroform extractions or cesium chloride banding required
- High yields of DNA recovered 3-15 µg DNA from 108-1010 pfu/ mL of enriched phages
- Phage whole genome sequencing services available
This kit provides a rapid spin column method for the purification of total DNA from a broad spectrum of bacteriophages propagated in bacteria grown in liquid cultures. The DNA is isolated without the use of phenol, chloroform or cesium chloride banding procedures. The spin-column based procedure is rapid and can be completed in less than 45 minutes. The kit is highly efficient for processing small volumes of phage supernatant (500 µL – 1 mL) and with the optional DNase and Proteinase K treatments phage DNA yields are maximized while host DNA contamination is minimized. Purified total phage DNA is of the highest integrity, and can be used in a number of downstream applications including PCR, qPCR, Restriction Fragment Length Polymorphism (RFLP), sequencing, cloning, Southern Blot and more.
Details
Supporting Data
Figure 1. Effective Host Genomic DNA Removal without Reducing Phage DNA Yield.
Total DNA was isolated from four enriched phage cultures using Norgen's Phage DNA Isolation Kit. A DNase I pre-treatment was performed prior to adding the provided Lysis Buffer. Briefly, 20 units of DNase I was added to 1 mL of enriched phage culture and the mixture was incubated at room temperature for 20 minutes. After the DNAase I treatment the procedure was followed. As a control, DNA was isolated from aliquots of the same 4 cultures using Norgen’s Phage DNA Isolation Kit without performing the DNase I treatment. For DNA analysis 10 µL of each 50 µL elution was loaded onto a 1X TAE agarose gel. As it can be seen, the phage DNA was safely protected from the DNase I treatment by its coat protein, while the host genomic DNA was efficiently degraded by the DNase I. Thus the DNase I pre-treatment resulted in less host gDNA contamination in the final phage elution without influencing the total phage DNA yield. Lane M is Norgen's Highranger 1 kb DNA Ladder (Cat. 11900)
Figure 2. Optional Proteinase K Treatment Improves DNA Yield for Certain Phage Strains.
Total DNA was isolated with and without the optional Proteinase K treatment using Norgen's Phage DNA Isolation Kit. Briefly, 4 µL of Proteinase K (20 mg/mL) was added to 1 mL of enriched phage culture and incubated at 55°C for 15 minutes with the phage Lysis Buffer. After the Proteinase K treatment the procedure was followed. As a control, DNA was isolated from aliquots of the same 8 cultures using Norgen's Phage DNA Isolation Kit without performing the Proteinase K treatment. For DNA analysis 10 µL of each 50 µL elution was loaded onto a 1X TAE agarose gel and the yield of DNA was compared from the eight different phage types (lane 1 to 8). As it can be seen, the optional treatment of Proteinase K improved the phage DNA yield in Lanes 2, 5 and 6 dramatically. Lane M is Norgen's Highranger 1 kb DNA Ladder (Cat. 11900)
|
Kit Specifications
|
|
|
Column Binding Capacity
|
50 µg
|
|
Maximum Column Loading Volume
|
650 µL
|
|
Size of DNA Purified
|
All sizes
|
| Maximum Amount of Starting Material |
1 x 1010 pfu/mL enriched phages
|
| Average Yield* |
3-15 µg DNA from 108-1010 pfu/mL
of enriched phages |
| Time to Complete 10 Purifications |
45 minutes
|
* Average yields will vary depending upon a number conditions used and developmental stage.
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. This kit is stable for 1 year after the date of shipment.
| Component | Cat. 46800 (50 preps) | Cat. 46850 (100 preps) |
|---|---|---|
| Lysis Buffer B | 40 mL | 2 x 40 mL |
| Wash Solution A | 38 mL | 2 x 38 mL |
| Elution Buffer B | 8 mL | 2 x 8 mL |
| Spin Columns | 50 | 100 |
| Collection Tubes | 50 | 100 |
| Elution Tubes (1.7 mL) | 50 | 100 |
| Product Insert | 1 | 1 |
Documentation
- in a timely manner that considers the person's accessibility needs due to disability; and
- at a cost that is no more than the regular cost charged to other persons
FAQs
Column clogging may occur due to one or more of the following reasons:
- Centrifugation speed was too low or spin time was inadequate.
Check the centrifuge to ensure that it is capable of generating the required RPMs. Sufficient centrifugal force is required to move the liquid through the resin. Also, ensure that the correct spin times are followed. Spin for an additional minute if necessary.
- Bacterial debris in the lysate.
Ensure that the starting material is clarified phage supernatant. Remove bacterial debris from the initial phage supernatant by centrifugation at 10,000 × g for 5 minutes before beginning the protocol.
- The lysate/binding solution mixture is not homogeneous.
To ensure a homogeneous solution, vortex for 10-15 seconds before applying the lysate to the spin column.
- Centrifuge temperature is too low.
Ensure that the centrifuge remains at room temperature throughout the procedure. Temperatures below 20℃ may cause precipitates to form that can cause the columns to clog.
The yield of genomic DNA may be lower than expected due to the following:
- Ineffective propagation of phage and initial lysis step.
Refer to the manufacturer's recommendations for the propagation of the phage, including proper titer for inoculation, growth conditions, and bacterial host.
- Incomplete lysis of cells.
Ensure that the incubation was performed for 15 minutes at 65℃ after the addition of Lysis Buffer B. Also, perform optional digestion with Proteinase K in Step 1b during Lysate Preparation.
- Ethanol was not added to the Wash Solution A.
Ensure that 90 mL of 96 - 100% ethanol is added to the supplied Wash Solution A prior to use.
- The DNA elution is incomplete.
Ensure that all the DNA is eluted. If elution buffer remains in the column, use 14,000 g for the second centrifuge.
If the DNA does not perform well in downstream applications, it may be due to one or more of the following:
- DNA was not washed three times with the provided Wash Solution A.
Traces of salt from the binding step may remain in the sample if the column is not washed three times with the Wash Solution A. Salt may interfere with downstream applications and thus must be washed from the column.
- Ethanol carryover.
Ensure that the dry spin under the Column Wash procedure is performed in order to remove traces of ethanol prior to elution. Ethanol is known to interfere with many downstream applications.
Host genomic DNA can contaminate the phage DNA. In order to eliminate host genomic DNA contamination in the phage DNA elution, it is recommended that a DNase I treatment is performed at the beginning of the lysate preparation procedure (see Section 1, Optional DNase Treatment).
Yes, the kit can isolate both ssDNA and dsDNA phage genomes.
| Title | Effect and mechanism of prophage lysogeny on antimicrobial resistance and virulence of Staphylococcus aureus from retail meat |
| Citation | Food Research International 2026. |
| Authors | Wenyuan Zhou, Wenjuan Li, Yeling Han, Aiping Deng, Yajie Li, Lei Yuan, Dan Xiong, Guoqiang Zhu, Zhenquan Yang |
| Title | Genome delivery of a contractile tailed phage and its superinfection exclusion mechanism |
| Citation | bioRxiv 2026. |
| Authors | Aritz Roa-Eguiara, Leyre Marín-Arraiza, Victor Klein-Sousa, Mònica Santiveri, Nicole R. Rutbeek, Damien Piel, Tillmann Pape, Nicholas Sofos, Ivo Alexander Hendriks, Michael Lund Nielsen, Haidai Hu, Alexander Harms, Nicholas M. I. Taylor |
| Title | Characterizations, genomic analysis, and antibioflim efficacy study of novel broadspectrum virulent bacteriophages Sfin-3, Sfin-4, and Sfin-5 targeting MDR clinical isolates of Shigella spp |
| Citation | Research Square 2026. |
| Authors | Chiranjib Guin. Bidisha Das, Srijana Rai, S. K. Tousif Ahamed, Subhajit Dutta, V. Balaji, Madhumathi Irulappan, Anirban Nandi, Somasri Dam, Utpal Basu, Nabanita Giri |
| Title | Complete genome sequence of the phage UNICOR_HM-QL, a Berlinvirus infecting Escherichia coli and Salmonella with potential for biocontrol in milk for Costeño cheese production |
| Citation | Bacteriophages 2026. |
| Authors | Fernando Mendoza-Corvis, Pedro Marcus Pereira Vidigal, Humberto Moreira Hungaro, Omar Perez Sierra, Ana Maria Hernández Arteaga, Maryoris E. Soto Lopez |
| Title | IMPACT OF BACTERIOPHAGE PRESENCE ON ESBL PLASMID EVOLUTION |
| Citation | Thesis 2026. |
| Authors | Elina Ylihonkaluoma |
| Title | Isolation and Characterization of bacteriophage from environmental soil samples |
| Citation | Independent study 2026. |
| Authors | Denish Khimdung |
| Title | Isolation and Characterization of a Novel Lytic Phage vB_Sen-P10 with Biocontrol Potential Against Salmonella Enteritidis in Food Systems |
| Citation | Food and Bioprocess Technology 2026. |
| Authors | Nida Nur Urganci, Zeliha Yildirim & Bahareh Rezaeian Tabrizi |
| Title | Structures and enzymatic mechanisms of DRT7/UG10 antiphage reverse transcriptases |
| Citation | bioRxiv 2026. |
| Authors | Małgorzata Figiel, Vysakh Komathattu Viswanath, Mariusz Czarnocki-Cieciura, Markéta Šoltysová, Julia Rybakowska, Artyom A. Egorov, Vasili Hauryliuk, Marcus J. O. Johansson, Marcin Nowotny |
| Title | Biocontrol of Listeria monocytogenes in milk: Isolation and characterization of a novel bacteriophage cocktail |
| Citation | International Dairy Journal 2026. |
| Authors | Gizem Cufaoglu, Ayse Nur Erdinc, Ilgın Ata Vural, Gorkem Cengiz, Bahar Onaran Acar, Gultekin Unal, Muammer Goncuoglu, Irfan Erol , Bilge Alpaslan Kocamemi, Ahmet Bestil, Ayçe Fadime Düzenli, Tansu Yıldız, Naim Deniz Ayaz |
| Title | Functional mechanism and clinical implications of lncRNA NNT-AS1 in delayed fracture healing |
| Citation | Cytotechnology 2026. |
| Authors | Phil Huss, Chutikarn Chitboonthavisuk, Anthony Meger, Kyle Nishikawa, R. P. Oates, Heath Mills, Olivia Holzhaus, Srivatsan Raman |
Related Products
2 ProductsNGS Services
Free trials available for Small RNA and RNA sequencing projects!
Book Consultation Learn More